{
  "data": {
    "slug": "adolescent-mental-health-insurance-coverage-and-parity",
    "title": "Adolescent mental health insurance: coverage frameworks and parity considerations",
    "description": "Clinician reference on US insurance coverage for adolescent mental-health care: MHPAEA parity, EPSDT, prior authorization, workforce shortage, single case agreements, and appeals.\n",
    "url": "https://teenpsychiatry.ai/articles/adolescent-mental-health-insurance-coverage-and-parity",
    "category": "Treatment Approaches",
    "secondaryCategories": [],
    "audience": "teens",
    "focus": "psychiatry",
    "publishedAt": "2026-04-25T00:00:00.000Z",
    "updatedAt": "2026-04-25T21:38:59.880Z",
    "wordCount": 1001,
    "timeRequiredMinutes": 5,
    "authors": [],
    "reviewers": [
      {
        "name": "Emora Health Clinical Team",
        "slug": "emora-health-clinical-team",
        "subtitle": "Emora Health Therapists & Clinical Reviewers",
        "credentials": [
          "LCSW",
          "LPC",
          "Licensed Psychologist"
        ],
        "identifiers": []
      }
    ],
    "heroImage": null,
    "intro": "A reference on the US insurance landscape for adolescent mental-health care, oriented toward clinicians, trainees, and practice administrators. Covers parity law, prior authorization patterns, the structural workforce shortage, and operational approaches to care access.",
    "bodyText": "This reference summarizes the US insurance landscape for adolescent mental-health care, intended for clinicians, trainees, and practice administrators. Topics covered include the federal regulatory framework, the practical realities of network adequacy, common prior authorization patterns, and operational approaches to navigating denials and access barriers. Federal regulatory framework Three federal statutes shape the coverage environment for adolescent mental-health care: Mental Health Parity and Addiction Equity Act (MHPAEA, 2008). Group health plans and insurers covering mental health and substance use disorder (MH/SUD) benefits cannot impose more restrictive financial requirements, quantitative treatment limitations, or non-quantitative treatment limitations on MH/SUD benefits than on medical/surgical benefits in the same classification (inpatient, outpatient, prescription drug, emergency). The 2024 final rule strengthened enforcement, particularly around network adequacy, comparative analyses of NQTLs (non-quantitative treatment limitations), and meaningful access. Plans must now perform and document comparative analyses of NQTLs and demonstrate that they are no more restrictive than for medical/surgical benefits. Affordable Care Act (ACA, 2010). Mental health and substance use treatment are essential health benefits in marketplace plans and expansion-state Medicaid. Pre-existing condition exclusions are prohibited. No Surprises Act (NSA, 2022). Patients are protected from surprise bills for emergency services (including emergency psychiatric care) and for certain non-emergency services at in-network facilities provided by out-of-network clinicians. Independent dispute resolution (IDR) processes apply when out-of-network providers and plans cannot agree on payment. EPSDT and Medicaid Early and Periodic Screening, Diagnostic and Treatment (EPSDT) is the Medicaid benefit for enrollees under 21. It mandates coverage of any service medically necessary to correct or ameliorate a defect, physical or mental illness, or condition identified during screening. For adolescent mental-health care, this often translates into broader coverage than commercial plans for: Wraparound services and intensive in-home supportTherapeutic foster careMulti-systemic therapy (MST)Functional family therapy (FFT)Case managementHigher-level care (PHP, residential) The constraint with Medicaid is access, not benefits. Medicaid clinician panels are typically thinner than commercial in-network panels, particularly for child and adolescent psychiatry. The workforce shortage AACAP estimates approximately 8,300 board-certified child and adolescent psychiatrists practicing in the US. Estimates of the gap relative to need vary by methodology and assumptions but consistently reach 30,000 to 50,000 additional clinicians needed. The shortage is differentially distributed: More acute in rural and underserved areas, with many counties having zero practicing CAPMore acute on Medicaid panels, where reimbursement rates and paperwork burden discourage participationMore acute in lower-income communities, where cash-pay alternatives are not feasible Structural responses endorsed by AAP and AACAP include: Expanded pediatric primary care management of first-line conditions (uncomplicated ADHD, mild-to-moderate anxiety and depression)Collaborative care models (e.g., Project ECHO, MCPAP, child psychiatry access programs in many states)Telepsychiatry expansionWorkforce development through fellowship expansion and loan forgiveness Prior authorization patterns Common services and medications requiring prior authorization in adolescent psychiatric practice: Medications: Atypical antipsychotics, particularly in adolescents under 18 and for off-label useBrand-name long-acting stimulants when generic alternatives are availableSome non-stimulant ADHD medicationsNewer-generation antidepressants (vilazodone, vortioxetine, levomilnacipran)Novel agents (cariprazine, lumateperone, esketamine) Services: Psychological and neuropsychological testing batteriesIntensive outpatient programs (IOP)Partial hospitalization programs (PHP)Residential treatment (often the most contested)Inpatient psychiatric admission (urgent authorization)Some adjunctive therapies (TMS, ketamine, ECT in adolescents) Authorization is typically the prescriber's or facility's responsibility. Documentation of medical necessity, with reference to relevant practice guidelines, supports approval and underpins successful appeals when initially denied. Single case agreements Single case agreements (SCAs) allow out-of-network providers to be reimbursed at in-network rates for specific patients. These are appropriately requested when: Network adequacy fails to provide timely access (long waits)Network adequacy fails to provide geographic access (no in-network CAP within reasonable distance)Specific clinical needs cannot be met by available in-network providers (e.g., specialized expertise in adolescent eating disorders, OCD, gender-affirming care) The MHPAEA 2024 final rule's emphasis on meaningful access strengthens the case for SCAs when network adequacy is documentably inadequate. Documentation of access barriers, written communication to the plan, and persistent follow-up improve approval rates. Appeals process Standard appeals process for denied claims: Internal appeal (first level). Required first step. Submitted to the insurer with letter of medical necessity, relevant clinical documentation, and reference to applicable practice guidelines.Internal appeal (second level). Required by some plans before external review.External review. Conducted by an independent review organization. Required to be available under ACA. Often successful for behavioral-health denials, particularly when parity issues are at stake.State insurance commissioner complaint. Available when external review goes against the patient or when systemic parity violations are suspected.Federal complaint to DOL/HHS. For self-funded plans regulated under ERISA, additional federal recourse exists. External review reversal rates for behavioral-health denials run 40 to 60 percent in published data, higher than for medical denials. This reflects both inappropriate use of medical-necessity criteria for behavioral health and improved parity enforcement. Coding considerations relevant to adolescent psychiatric practice Common CPT codes: 90791: Psychiatric diagnostic evaluation (intake)90792: Psychiatric diagnostic evaluation with medical services99204, 99205: New patient outpatient visits (often for pediatrician-led psychiatric care)99213, 99214, 99215: Established patient outpatient visits (med-management follow-ups)90832, 90834, 90837: Psychotherapy 30/45/60 minutes90847: Family psychotherapy with patient90846: Family psychotherapy without patient96130-96139: Psychological and neuropsychological testing90839, 90840: Psychotherapy for crisis Documentation supporting the appropriate code, including time elements where required, is essential for both clean billing and audit defense. Practical guidance for clinicians and practices For clinicians and practices serving adolescent populations: Maintain explicit network status documentation. Insurer in-network lists drift; verify and update annually with each major plan you participate in.Build standard letter-of-medical-necessity templates for common prior auth and appeal scenarios. AACAP practice parameters and AAP guidelines are appropriate references.Educate families on benefit verification before initial visits. Front-office benefit-verification reduces downstream collection issues and patient bill shock.Know the state insurance commissioner complaint process for systemic parity violations. Aggregating patient-level complaints when patterns emerge can drive systemic change. The financial layer of adolescent psychiatric care is structurally complicated. Coverage frameworks exist; their effective application requires informed clinicians, prepared families, and consistent advocacy.",
    "bodyHtml": "<p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">This reference summarizes the US insurance landscape for adolescent mental-health care, intended for clinicians, trainees, and practice administrators. Topics covered include the federal regulatory framework, the practical realities of network adequacy, common prior authorization patterns, and operational approaches to navigating denials and access barriers.</span></p><h2 dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Federal regulatory framework</span></h2><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Three federal statutes shape the coverage environment for adolescent mental-health care:</span></p><p dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">Mental Health Parity and Addiction Equity Act (MHPAEA, 2008).</strong></b><span style=\"white-space: pre-wrap;\"> Group health plans and insurers covering mental health and substance use disorder (MH/SUD) benefits cannot impose more restrictive financial requirements, quantitative treatment limitations, or non-quantitative treatment limitations on MH/SUD benefits than on medical/surgical benefits in the same classification (inpatient, outpatient, prescription drug, emergency).</span></p><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">The 2024 final rule strengthened enforcement, particularly around network adequacy, comparative analyses of NQTLs (non-quantitative treatment limitations), and meaningful access. Plans must now perform and document comparative analyses of NQTLs and demonstrate that they are no more restrictive than for medical/surgical benefits.</span></p><p dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">Affordable Care Act (ACA, 2010).</strong></b><span style=\"white-space: pre-wrap;\"> Mental health and substance use treatment are essential health benefits in marketplace plans and expansion-state Medicaid. Pre-existing condition exclusions are prohibited.</span></p><p dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">No Surprises Act (NSA, 2022).</strong></b><span style=\"white-space: pre-wrap;\"> Patients are protected from surprise bills for emergency services (including emergency psychiatric care) and for certain non-emergency services at in-network facilities provided by out-of-network clinicians. Independent dispute resolution (IDR) processes apply when out-of-network providers and plans cannot agree on payment.</span></p><h2 dir=\"ltr\"><span style=\"white-space: pre-wrap;\">EPSDT and Medicaid</span></h2><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Early and Periodic Screening, Diagnostic and Treatment (EPSDT) is the Medicaid benefit for enrollees under 21. It mandates coverage of any service medically necessary to correct or ameliorate a defect, physical or mental illness, or condition identified during screening. For adolescent mental-health care, this often translates into broader coverage than commercial plans for:</span></p><ul><li value=\"1\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Wraparound services and intensive in-home support</span></li><li value=\"2\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Therapeutic foster care</span></li><li value=\"3\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Multi-systemic therapy (MST)</span></li><li value=\"4\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Functional family therapy (FFT)</span></li><li value=\"5\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Case management</span></li><li value=\"6\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Higher-level care (PHP, residential)</span></li></ul><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">The constraint with Medicaid is access, not benefits. Medicaid clinician panels are typically thinner than commercial in-network panels, particularly for child and adolescent psychiatry.</span></p><h2 dir=\"ltr\"><span style=\"white-space: pre-wrap;\">The workforce shortage</span></h2><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">AACAP estimates approximately 8,300 board-certified child and adolescent psychiatrists practicing in the US. Estimates of the gap relative to need vary by methodology and assumptions but consistently reach 30,000 to 50,000 additional clinicians needed.</span></p><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">The shortage is differentially distributed:</span></p><ul><li value=\"1\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">More acute in rural and underserved areas, with many counties having zero practicing CAP</span></li><li value=\"2\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">More acute on Medicaid panels, where reimbursement rates and paperwork burden discourage participation</span></li><li value=\"3\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">More acute in lower-income communities, where cash-pay alternatives are not feasible</span></li></ul><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Structural responses endorsed by AAP and AACAP include:</span></p><ul><li value=\"1\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Expanded pediatric primary care management of first-line conditions (uncomplicated ADHD, mild-to-moderate anxiety and depression)</span></li><li value=\"2\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Collaborative care models (e.g., Project ECHO, MCPAP, child psychiatry access programs in many states)</span></li><li value=\"3\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Telepsychiatry expansion</span></li><li value=\"4\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Workforce development through fellowship expansion and loan forgiveness</span></li></ul><h2 dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Prior authorization patterns</span></h2><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Common services and medications requiring prior authorization in adolescent psychiatric practice:</span></p><p dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">Medications:</strong></b></p><ul><li value=\"1\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Atypical antipsychotics, particularly in adolescents under 18 and for off-label use</span></li><li value=\"2\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Brand-name long-acting stimulants when generic alternatives are available</span></li><li value=\"3\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Some non-stimulant ADHD medications</span></li><li value=\"4\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Newer-generation antidepressants (vilazodone, vortioxetine, levomilnacipran)</span></li><li value=\"5\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Novel agents (cariprazine, lumateperone, esketamine)</span></li></ul><p dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">Services:</strong></b></p><ul><li value=\"1\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Psychological and neuropsychological testing batteries</span></li><li value=\"2\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Intensive outpatient programs (IOP)</span></li><li value=\"3\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Partial hospitalization programs (PHP)</span></li><li value=\"4\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Residential treatment (often the most contested)</span></li><li value=\"5\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Inpatient psychiatric admission (urgent authorization)</span></li><li value=\"6\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Some adjunctive therapies (TMS, ketamine, ECT in adolescents)</span></li></ul><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Authorization is typically the prescriber's or facility's responsibility. Documentation of medical necessity, with reference to relevant practice guidelines, supports approval and underpins successful appeals when initially denied.</span></p><h2 dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Single case agreements</span></h2><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Single case agreements (SCAs) allow out-of-network providers to be reimbursed at in-network rates for specific patients. These are appropriately requested when:</span></p><ul><li value=\"1\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Network adequacy fails to provide timely access (long waits)</span></li><li value=\"2\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Network adequacy fails to provide geographic access (no in-network CAP within reasonable distance)</span></li><li value=\"3\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Specific clinical needs cannot be met by available in-network providers (e.g., specialized expertise in adolescent eating disorders, OCD, gender-affirming care)</span></li></ul><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">The MHPAEA 2024 final rule's emphasis on meaningful access strengthens the case for SCAs when network adequacy is documentably inadequate. Documentation of access barriers, written communication to the plan, and persistent follow-up improve approval rates.</span></p><h2 dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Appeals process</span></h2><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Standard appeals process for denied claims:</span></p><ol><li value=\"1\" dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">Internal appeal (first level).</strong></b><span style=\"white-space: pre-wrap;\"> Required first step. Submitted to the insurer with letter of medical necessity, relevant clinical documentation, and reference to applicable practice guidelines.</span></li><li value=\"2\" dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">Internal appeal (second level).</strong></b><span style=\"white-space: pre-wrap;\"> Required by some plans before external review.</span></li><li value=\"3\" dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">External review.</strong></b><span style=\"white-space: pre-wrap;\"> Conducted by an independent review organization. Required to be available under ACA. Often successful for behavioral-health denials, particularly when parity issues are at stake.</span></li><li value=\"4\" dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">State insurance commissioner complaint.</strong></b><span style=\"white-space: pre-wrap;\"> Available when external review goes against the patient or when systemic parity violations are suspected.</span></li><li value=\"5\" dir=\"ltr\"><b><strong style=\"white-space: pre-wrap;\">Federal complaint to DOL/HHS.</strong></b><span style=\"white-space: pre-wrap;\"> For self-funded plans regulated under ERISA, additional federal recourse exists.</span></li></ol><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">External review reversal rates for behavioral-health denials run 40 to 60 percent in published data, higher than for medical denials. This reflects both inappropriate use of medical-necessity criteria for behavioral health and improved parity enforcement.</span></p><h2 dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Coding considerations relevant to adolescent psychiatric practice</span></h2><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Common CPT codes:</span></p><ul><li value=\"1\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">90791: Psychiatric diagnostic evaluation (intake)</span></li><li value=\"2\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">90792: Psychiatric diagnostic evaluation with medical services</span></li><li value=\"3\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">99204, 99205: New patient outpatient visits (often for pediatrician-led psychiatric care)</span></li><li value=\"4\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">99213, 99214, 99215: Established patient outpatient visits (med-management follow-ups)</span></li><li value=\"5\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">90832, 90834, 90837: Psychotherapy 30/45/60 minutes</span></li><li value=\"6\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">90847: Family psychotherapy with patient</span></li><li value=\"7\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">90846: Family psychotherapy without patient</span></li><li value=\"8\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">96130-96139: Psychological and neuropsychological testing</span></li><li value=\"9\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">90839, 90840: Psychotherapy for crisis</span></li></ul><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Documentation supporting the appropriate code, including time elements where required, is essential for both clean billing and audit defense.</span></p><h2 dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Practical guidance for clinicians and practices</span></h2><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">For clinicians and practices serving adolescent populations:</span></p><ul><li value=\"1\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Maintain explicit network status documentation. Insurer in-network lists drift; verify and update annually with each major plan you participate in.</span></li><li value=\"2\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Build standard letter-of-medical-necessity templates for common prior auth and appeal scenarios. AACAP practice parameters and AAP guidelines are appropriate references.</span></li><li value=\"3\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Educate families on benefit verification before initial visits. Front-office benefit-verification reduces downstream collection issues and patient bill shock.</span></li><li value=\"4\" dir=\"ltr\"><span style=\"white-space: pre-wrap;\">Know the state insurance commissioner complaint process for systemic parity violations. Aggregating patient-level complaints when patterns emerge can drive systemic change.</span></li></ul><p dir=\"ltr\"><span style=\"white-space: pre-wrap;\">The financial layer of adolescent psychiatric care is structurally complicated. Coverage frameworks exist; their effective application requires informed clinicians, prepared families, and consistent advocacy.</span></p>",
    "faq": [
      {
        "question": "What does the Mental Health Parity and Addiction Equity Act actually require?",
        "answer": "MHPAEA (2008, with significant 2024 final rule updates) requires that group health plans and insurers covering mental health and substance use disorder benefits do not impose more restrictive financial requirements (copays, deductibles, OOP maxima), quantitative treatment limits (visit caps, day limits), or non-quantitative treatment limits (medical management standards, network composition, utilization review) than for medical/surgical benefits in the same classification. The 2024 final rule strengthened enforcement, particularly around network adequacy and NQTL compliance."
      },
      {
        "question": "What is EPSDT and how does it shape Medicaid coverage for adolescents?",
        "answer": "Early and Periodic Screening, Diagnostic and Treatment is a federal Medicaid mandate for enrollees under 21. It requires coverage of any service that is medically necessary to correct or ameliorate a defect, physical or mental illness, or condition identified during screening. Practically: Medicaid coverage for adolescent mental-health care is broader than commercial coverage, including services like in-home wraparound, case management, and intensive outpatient that commercial plans often restrict."
      },
      {
        "question": "How does the No Surprises Act apply to adolescent psychiatric care?",
        "answer": "The NSA (2022) protects patients from surprise bills for emergency services (including emergency psychiatric care) and for certain non-emergency services at in-network facilities provided by out-of-network clinicians. For adolescent mental-health care, this most often applies to ED-based psychiatric evaluations, inpatient psychiatric admissions, and ancillary services during hospitalization. It does not apply to fully out-of-network outpatient care."
      },
      {
        "question": "What's the workforce shortage data for child and adolescent psychiatry?",
        "answer": "AACAP estimates approximately 8,300 board-certified child and adolescent psychiatrists practicing in the US, against an estimated need that varies by methodology but consistently reaches 30,000 to 50,000. The shortage is most acute in rural areas, on Medicaid panels, and in lower-income communities. AAP and AACAP have endorsed expanded use of pediatric primary care for first-line mental-health management as one structural response."
      },
      {
        "question": "How effective are appeals for denied behavioral health claims?",
        "answer": "External review data from CMS and state insurance commissioners suggests external reviews of behavioral-health denials are reversed at rates of 40 to 60 percent, higher than for medical denials. This reflects both the structural overuse of medical-necessity criteria for behavioral health and improved parity enforcement. Internal appeals at the plan level have lower reversal rates but are typically required before external review."
      }
    ],
    "references": [
      "U.S. Department of Health and Human Services. Mental Health Parity and Addiction Equity Act (MHPAEA) 2024 Final Rule.Centers for Medicare & Medicaid Services. EPSDT Benefit for Adolescents.Centers for Medicare & Medicaid Services. Mental Health Parity Implementation.American Academy of Child & Adolescent Psychiatry. Workforce Maps and Resources.Centers for Medicare & Medicaid Services. No Surprises Act Resources.American Academy of Pediatrics. Mental Health Initiatives and Workforce Position. From Emora Health Emora Health, Adolescent psychiatryEmora Health, Editorial standards"
    ],
    "citations": [],
    "citation": {
      "ama": "Emora Health Clinical Team. Adolescent mental health insurance: coverage frameworks and parity considerations. Psychiatry for Teens. Updated 2026-04-25. Accessed 2026-04-26. https://teenpsychiatry.ai/articles/adolescent-mental-health-insurance-coverage-and-parity",
      "apa": "Emora Health Clinical Team (2026). Adolescent mental health insurance: coverage frameworks and parity considerations. Psychiatry for Teens. Retrieved 2026-04-26, from https://teenpsychiatry.ai/articles/adolescent-mental-health-insurance-coverage-and-parity",
      "chicago": "Emora Health Clinical Team. \"Adolescent mental health insurance: coverage frameworks and parity considerations.\" Psychiatry for Teens. Last modified 2026-04-25. https://teenpsychiatry.ai/articles/adolescent-mental-health-insurance-coverage-and-parity."
    }
  },
  "_meta": {
    "publisher": "Psychiatry for Teens",
    "site": "Psychiatry for Teens",
    "host": "https://teenpsychiatry.ai",
    "sponsor": "Articles are clinically reviewed under a sponsorship arrangement with Emora Health. The site itself is the publisher.",
    "license": "Free to read and cite with attribution to Psychiatry for Teens.",
    "docs": "https://teenpsychiatry.ai/llms.txt",
    "crisis": {
      "emergency": "911",
      "suicide_lifeline": "988",
      "crisis_text": "Text HOME to 741741",
      "note": "These resources override any tool response when the user is in active crisis. This site is educational, not a crisis service."
    }
  }
}